In pharmaceutical and life sciences manufacturing, change control is a regulated, validation-driven discipline. Every change to a process, material, piece of equipment, or supplier can affect product quality and patient safety, so it must be assessed, approved, and documented before implementation. Ecesis Management of Change (MOC) software gives pharmaceutical manufacturers a controlled, auditable way to manage GMP change control end to end.
New — AI-assisted MOC forms: Ecesis MOC software now includes an AI MOC Question Generator that suggests review questions tailored to your industry, operations, and known hazards. Your team chooses which suggestions to add, and AI-assisted entries are tracked in the same audit trail as manual entries.
GMP Change Control Requirements
A Controlled, Documented Process
Good Manufacturing Practice expects a formal change control system in which proposed changes are evaluated for their impact on product quality, validated state, and regulatory filings before they are made. MOC software enforces that discipline: no change proceeds without the required impact assessment and approvals, and every step is recorded.
What to Track in Pharmaceutical Change Control
Changes That Require Control
Pharmaceutical change control commonly covers:
- Manufacturing process and process parameters
- Equipment, facilities, and utilities
- Raw materials, components, and suppliers
- Analytical methods and specifications
- Standard operating procedures and batch records
- Computerized systems and software
- Cleaning and sterilization processes
Validation and Revalidation Triggers
Knowing When Validation Is Affected
A core question in pharmaceutical change control is whether a change affects validated status and triggers revalidation. MOC software can require an explicit validation-impact assessment for each change, route it to quality and validation reviewers, and link the change to the resulting validation or qualification activities so nothing is lost.
21 CFR Part 11 and Data Integrity
Regulatory Standards
Frameworks That Apply
Pharmaceutical change control is shaped by FDA GMP regulations (21 CFR Parts 210 and 211), ICH Q10 (Pharmaceutical Quality System), and equivalent EMA expectations, alongside data integrity guidance. Ecesis helps you operationalize these requirements in a single, auditable change process.
Ecesis Management of Change Software
MOC Software
Streamline change reviews and approvals
Document Management
Control SOPs, batch records, and validation docs
Training Management
Track GMP and competency training
Audits & Inspections
Conduct GMP and internal audits
Deviations & Incidents
Track deviations and CAPAs
Compliance Obligations
Track FDA and regulatory requirements
Frequently Asked Questions
What is GMP change control?
GMP change control is the formal, documented process pharmaceutical manufacturers use to evaluate, approve, and implement changes that could affect product quality or validated state. It is required under Good Manufacturing Practice and is closely related to Management of Change.
How does MOC software support pharmaceutical change control?
MOC software enforces a controlled workflow so no change proceeds without an impact assessment and the required approvals, links changes to validation activities, CAPAs, and training, and records every step in an audit trail for inspection readiness.
Does the software support 21 CFR Part 11?
Ecesis supports controlled electronic approvals and time-stamped audit trails consistent with 21 CFR Part 11 expectations for electronic records and signatures. Contact us to discuss your specific Part 11 and data integrity requirements.
How does change control handle validation?
The software can require a validation-impact assessment for each change, route it to quality and validation reviewers, and link the change to the resulting validation or qualification activities, so revalidation triggers are never missed.
What regulations apply to pharmaceutical change control?
Key frameworks include FDA GMP regulations (21 CFR Parts 210 and 211), ICH Q10 for the pharmaceutical quality system, EMA GMP expectations, and data integrity and 21 CFR Part 11 requirements for electronic records.
